Other Hospital Services - Australia

Australia

In Australia, the revenue in the Other Hospital Services market is forecasted to achieve a significant milestone, reaching a staggering €4.01bn by the year 2024.
This projection is indicative of a promising growth trajectory for this market.
Furthermore, it is anticipated that the revenue will continue to exhibit a steady upward trend, with an estimated compound annual growth rate (CAGR 2024-2029) of 1.17%.
This positive growth rate is expected to propel the market volume to reach an impressive €4.25bn by 2029.
When comparing the global landscape, it is noteworthy that China is projected to be the frontrunner in terms of revenue generation in this market.
In 2024 alone, China is expected to generate a remarkable revenue of €91,600.00m.
This highlights the dominance of the Chinese market on a global scale.
Australia is experiencing a growing trend in the demand for alternative hospital services such as naturopathy and acupuncture.

Key regions: Germany, United States, China, France, Brazil

Mercado

Región

Comparación de regiones

Moneda

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.